Healthcare company Sanofi Aventis France said it had been placed under formal investigation on charges of manslaughter over Depakine, which is an epilepsy drug that caused birth malfunctions and slow neurological development when taken during pregnancy, reports Reuters.
You are a subscriber
Login
If you are not already a subscriber,
subscribe here
Choose a subscription offer and create your account to read all content on Mediapart
Create your account